Long non‑coding RNA SNHG9 inhibits ovarian cancer progression by sponging microRNA‑214‑5p

Chen,Gao-Yang; Zhang,Zhi-Sheng; Chen,Yu; Li,Yan

doi:10.3892/ol.2020.12341

Long non‑coding RNA SNHG9 inhibits ovarian cancer progression by sponging microRNA‑214‑5p

Authors:
- Gao-Yang Chen
- Zhi-Sheng Zhang
- Yu Chen
- Yan Li
View Affiliations

Affiliations: Department of Oncology, The Second People's Hospital of Taizhou City, Taizhou, Jiangsu 225300, P.R. China, Department of Oncology, Second Hospital of Shandong University, Jinan, Shandong 250000, P.R. China, Department of Obstetrics and Gynecology, The Second People's Hospital of Taizhou City, Taizhou, Jiangsu 225300, P.R. China
Published online on: November 30, 2020 https://doi.org/10.3892/ol.2020.12341
Article Number: 80
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ovarian cancer ranks 7th among the most common cancer types affecting women worldwide. A number of studies have confirmed that multiple long non‑coding RNAs participate in the occurrence and progression of ovarian cancer. Small nucleolar RNA host gene 9 (SNHG9) serves a role in the progression of glioblastoma and pancreatic cancer. However, the specific biological function of SNHG9 in ovarian cancer has not yet been fully investigated. The present study aimed to determine the biological role and potential molecular mechanism underlying the influence of SNHG9 in ovarian cancer. SNHG9 expression in ovarian cancer cell lines and tissues were measured via reverse transcription‑quantitative PCR analysis, and cell proliferation was detected via Cell Counting Kit‑8 and colony formation assays. Flow cytometry was performed to assess cell cycle progression, and Transwell and wound healing assays were performed to assess cell invasion and migration abilities. Bioinformatics software was utilized to determine the target genes of SNHG9, which were subsequently verified via dual‑luciferase reporter and RNA immunoprecipitation assays. The results demonstrated that SNHG9 expression was remarkably lower in ovarian cancer cell lines and tissues compared with the negative controls. Cell function assays demonstrated that decreased SNHG9 expression notably induced the migration, colony formation, proliferation and invasiveness of ovarian cancer cells. Furthermore, the inhibitory effect of SNHG9 on the migration, colony formation, proliferation and invasion of ovarian cancer cells was partially reversed by miR‑214‑5p upregulation. Thus, taken together, the current results suggest that SNHG9 may serve as a tumor suppressor gene in ovarian cancer by regulating the miR‑214‑5p/cryptochrome circadian regulator 2 axis.

View Figures

View References

1	Tew WP: Ovarian cancer in the older woman. J Geriatr Oncol. 7:354–361. 2016. View Article : Google Scholar
2	Webb PM and Jordan SJ: Epidemiology of epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 41:3–14. 2017. View Article : Google Scholar
3	Dong X, Men X, Zhang W and Lei P: Advances in tumor markers of ovarian cancer for early diagnosis. Indian J Cancer. 51 (Suppl 3):e72–e76. 2014. View Article : Google Scholar
4	Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfard S, Coffman EJ, Contino G, Deshpande V, Iafrate AJ, Letovsky S, et al: Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science. 331:593–596. 2011. View Article : Google Scholar
5	Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY and Hua KQ: Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer. Int J Oncol. 46:2497–2505. 2015. View Article : Google Scholar
6	Lai XJ and Cheng HF: lncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290. Eur Rev Med Pharmacol Sci. 22:322–328. 2018.
7	Liu SP, Yang JX, Cao DY and Shen K: Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med. 10:138–141. 2013.
8	Nikpayam E, Tasharrofi B, Sarrafzadeh S and Ghafouri-Fard S: The role of long non-coding RNAs in ovarian cancer. Iran Biomed J. 21:3–15. 2017. View Article : Google Scholar
9	Soudyab M, Iranpour M and Ghafouri-Fard S: The role of long non-coding RNAs in breast cancer. Arch Iran Med. 19:508–517. 2016.
10	Cech TR and Steitz JA: The noncoding RNA revolution-trashing old rules to forge new ones. Cell. 157:77–94. 2014. View Article : Google Scholar
11	Bunch H: Gene regulation of mammalian long non-coding RNA. Mol Genet Genomics. 293:1–15. 2018. View Article : Google Scholar
12	Zhou HL, Luo G, Wise JA and Lou H: Regulation of alternative splicing by local histone modifications: Potential roles for RNA-guided mechanisms. Nucleic Acids Res. 42:701–713. 2014. View Article : Google Scholar
13	Yang L, Kirby JE, Sunwoo H and Lee JT: Female mice lacking Xist RNA show partial dosage compensation and survive to term. Genes Dev. 30:1747–1760. 2016. View Article : Google Scholar
14	Kanduri C: Long noncoding RNAs: Lessons from genomic imprinting. Biochim Biophys Acta. 1859:102–111. 2016. View Article : Google Scholar
15	Malakootian M, Mirzadeh Azad F, Fouani Y, Taheri Bajgan E, Saberi H and Mowla SJ: Anti-differentiation non-coding RNA, ANCR, is differentially expressed in different types of brain tumors. J Neurooncol. 138:261–270. 2018. View Article : Google Scholar
16	Ranzani V, Arrigoni A, Rossetti G, Panzeri I, Abrignani S, Bonnal RJP and Pagani M: Next-generation sequencing analysis of long noncoding RNAs in CD4+ T cell differentiation. Methods Mol Biol. 1514:173–185. 2017. View Article : Google Scholar
17	Dong J, Xu J, Wang X and Jin B: Influence of the interaction between long noncoding RNAs and hypoxia on tumorigenesis. Tumour Biol. 37:1379–1385. 2016. View Article : Google Scholar
18	Lou Y, Jiang H, Cui Z, Wang L, Wang X and Tian T: Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling. Oncotarget. 8:69983–69994. 2017. View Article : Google Scholar
19	Zheng ZG, Xu H, Suo SS, Xu XL, Ni MW, Gu LH, Chen W, Wang LY, Zhao Y, Tian B and Hua YJ: The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer. Sci Rep. 6:260932016. View Article : Google Scholar
20	Gao C, Zhao D, Zhao Q, Dong D, Mu L, Zhao X, Guo M, Xu A, Fang L, Liu Q and Che J: Microarray profiling and co-expression network analysis of lncRNAs and mRNAs in ovarian cancer. Cell Death Discov. 5:932019. View Article : Google Scholar
21	Zhang B, Li C and Sun Z: Long non-coding RNA LINC00346, LINC00578, LINC00673, LINC00671, LINC00261, and SNHG9 are novel prognostic markers for pancreatic cancer. Am J Transl Res. 10:2648–2658. 2018.
22	Yu Y, Li Y, Zhou L, Yang G, Wang M and Hong Y: Cryptochrome 2 (CRY2) suppresses proliferation and migration and regulates clock gene network in osteosarcoma cells. Med Sci Monit. 24:3856–3862. 2018. View Article : Google Scholar
23	Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD, Wang L, Deng Y, Wang P, Wang J and Lee MH: Circadian clock gene CRY2 degradation is involved in chemoresistance of colorectal cancer. Mol Cancer Ther. 14:1476–1487. 2015. View Article : Google Scholar
24	Tokunaga H, Takebayashi Y, Utsunomiya H, Akahira JI, Higashimoto M, Mashiko M, Ito K, Niikura H, Takenoshita SI and Yaegashi N: Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstet Gynecol Scand. 87:1060–1070. 2008. View Article : Google Scholar
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
26	Helder-Woolderink JM, Blok EA, Vasen HF, Hollema H, Mourits MJ and De Bock GH: Ovarian cancer in Lynch syndrome; a systematic review. Eur J Cancer. 55:65–73. 2016. View Article : Google Scholar
27	Miao H, Wang L, Zhan H, Dai J, Chang Y, Wu F, Liu T, Liu Z, Gao C, Li L and Song X: A long noncoding RNA distributed in both nucleus and cytoplasm operates in the PYCARD-regulated apoptosis by coordinating the epigenetic and translational regulation. PLoS Genet. 15:e10081442019. View Article : Google Scholar
28	Liu L, Shen H and Wang Y: CRY2 is suppressed by FOXM1 mediated promoter hypermethylation in breast cancer. Biochem Biophys Res Commun. 490:44–50. 2017. View Article : Google Scholar
29	Li P, Tong L, Song Y, Sun J, Shi J, Wu Z, Diao Y, Li Y and Wang Z: Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion. J Cell Physiol. 234:4515–4527. 2019. View Article : Google Scholar
30	Yao P, Ni Y and Liu C: Long non-coding RNA 691 regulated PTEN/PI3K/AKT signaling pathway in osteosarcoma through miRNA-9-5p. Onco Targets Ther. 13:4597–4606. 2020. View Article : Google Scholar
31	Yu F, Zhou G, Huang K, Fan X, Li G, Chen B, Dong P and Zheng J: Serum lincRNA-p21 as a potential biomarker of liver fibrosis in chronic hepatitis B patients. J Viral Hepat. 24:580–588. 2017. View Article : Google Scholar
32	Birgani MT, Hajjari M, Shahrisa A, Khoshnevisan A, Shoja Z, Motahari P and Farhangi B: Long non-coding RNA SNHG6 as a potential biomarker for hepatocellular carcinoma. Pathol Oncol Res. 24:329–337. 2018. View Article : Google Scholar
33	Fu LL, Li CJ, Xu Y, Li LY, Zhou X, Li DD, Chen SX, Wang FG, Zhang XY and Zheng LW: Role of lncRNAs as novel biomarkers and therapeutic targets in ovarian cancer. Crit Rev Eukaryot Gene Expr. 27:183–195. 2017. View Article : Google Scholar
34	Zhao L, Ji G, Le X, Wang C, Xu L, Feng M, Zhang Y, Yang H, Xuan Y, Yang Y, et al: Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer. Cancer Res. 77:1369–1382. 2017. View Article : Google Scholar
35	Zhang LQ, Yang SQ, Wang Y, Fang Q, Chen XJ, Lu HS and Zhao LP: Long noncoding RNA MIR4697HG promotes cell growth and metastasis in human ovarian cancer. Anal Cell Pathol (Amst). 2017:82678632017.